Table 3.
HCT with G-CSF | HCT without G-CSF | p-value | |
---|---|---|---|
CMV | |||
Within 3-months after HCT | 32·1% (95% CI 28-37) | 28·1% (95% CI 24-33) | 0·196 |
Within 6 months after HCT | 33·9% (95% CI 30-38) | 29·1% (95% CI 25-34) | 0·123 |
EBV | |||
Within 3-months after HCT | 17·7% (95% CI 14-21) | 10·4% (95% CI 8-14) | 0·002 |
Within 6 months after HCT | 19·1% (95% CI 16-23) | 11·4% (95% CI 9-15) | 0·002 |
Other* | |||
Within 3-months after HCT | 22·5% (95% CI 19-27) | 16·0% (95% CI 13-20) | 0·013 |
Within 6 months after HCT | 26·1% (95% CI 22-30) | 19·2% (95% CI 16-23) | 0·016 |
Abbreviation:
HCT = hematopoietic cell transplant
G-CSF = granulocyte colony stimulating factor
CMV = Cytomegalovirus
EBV = Epstein Barr virus
Other includes adenovirus, herpesviridae and respiratory viruses.